Viewing Study NCT00069758


Ignite Creation Date: 2025-12-25 @ 12:09 AM
Ignite Modification Date: 2025-12-25 @ 10:09 PM
Study NCT ID: NCT00069758
Status: COMPLETED
Last Update Posted: 2014-05-09
First Post: 2003-09-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma
Sponsor: Cephalon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module